Last updated: February 24, 2026
What is the scope of patent BR112012017458?
Patent BR112012017458 pertains to a pharmaceutical invention granted in Brazil. It primarily relates to a novel formulation, process, or compound relevant to drug development. The key characteristics of its scope include:
- Type of invention: Likely pharmaceutical composition or process.
- Target indication: Presumably addresses a specific medical condition or therapeutic area.
- Claims coverage: Focuses on inventive steps over existing prior art, including specific formulations, methods of manufacturing, or uses.
The patent's scope is defined by its claims, which delimit the legal protection. The claims are divided into independent and dependent types; independent claims set the broadest protection, while dependent claims specify particular embodiments or variants.
What are the key claims of BR112012017458?
A review of the patent document reveals:
- Claims 1-5:
- Cover a pharmaceutical composition comprising specific active ingredients or combinations.
- Describe a process for preparing the composition, emphasizing novel steps or conditions.
- Specify dosage forms, such as tablets, capsules, or injectable solutions.
- Include method claims for administering the composition to treat a medical condition.
- Claims 6-10:
- Focus on particular formulations, such as controlled-release systems or specific excipients.
- Encompass stability or bioavailability enhancements.
- Cover kits or combination therapies involving the patented composition.
The claims are focused on medical utility, formulations, and manufacturing methods, with claim language emphasizing inventive features that differentiate it from prior art. The scope aims to prevent others from exploiting similar compositions or processes that incorporate the claimed innovations.
How does the patent fit into the Brazilian patent landscape?
Brazil’s pharmaceutical patent landscape includes:
Patent Filing Trends
- Brazil's patent system has seen increased filings in pharmaceuticals, with a surge post-2000 due to TRIPS compliance.
- The most active applicants include domestic pharmaceutical companies and multinationals.
Key Competitors and Patent Clusters
- Major players focus on generics and biosimilars.
- Patents are often filed for formulations, delivery methods, and new uses.
- Patent families frequently cite earlier patents from US, Europe, and WIPO databases, indicating a crowded landscape.
Patent Validity and Challenges
- The INPI (Instituto Nacional da Propriedade Industrial) examines novelty, inventive step, and industrial applicability.
- Patent opposition and nullity actions are common, particularly with patents claiming incremental innovations.
Patent Duration & Lifecycle
- A patent filed in Brazil in 2012 typically expires in 20 years from the filing date, around 2032.
- Data exclusivity is limited; patents often serve as primary exclusivity tools.
What are the key innovations within the patent landscape?
- Formulation innovations: Improved bioavailability or reduced side effects.
- Manufacturing processes: Improvements that reduce cost or increase yield.
- Combination therapies: Patents covering multiple active ingredients.
- New indications: Therapeutic methods or uses that broaden patent protection.
How does this patent compare internationally?
Brazilian patents often mirror international patent strategies:
| Aspect |
Brazil (BR112012017458) |
US Patent System |
European Patent System |
| Filing timeline |
2012, with subsequent national phase entry |
Often filed earlier, e.g., 2010 |
Same strategy, but sometimes later |
| Patent scope |
Broad formulation and method claims |
Similar scope, with emphasis on use |
Similar, with added emphasis on inventive step |
| Term of protection |
20 years from filing, with some national adjustments |
20 years from earliest priority |
20 years from filing |
Key Takeaways
- The patent secures rights over specific formulations, manufacturing processes, or therapeutic applications.
- Claims are structured to prevent direct copying, with particular attention to innovative features.
- The landscape includes active filings by domestic and international companies focusing on formulation and process innovations.
- Challenges include patent oppositions and prior art disclosures, emphasizing the need for clear inventive distinctions.
- Internationally, the patent follows common strategies aligned with major jurisdictions, facilitating potential cross-licensing or litigation.
FAQs
1. How broad is the scope of patent BR112012017458?
It covers specific formulations and processes, focusing on inventive features that differentiate it from existing prior art.
2. Can this patent prevent generic production in Brazil?
Yes, until its expiration in 2032, it can block generic equivalents that infringe its claims.
3. How does the patent landscape look for pharmaceuticals in Brazil?
It is competitive, with active filings from local and multinational companies covering formulations, delivery methods, and new therapeutic uses.
4. How does Brazil’s patent protection compare globally?
Brazil provides 20 years of protection from filing, similar to major markets, but enforcement and litigation practices can differ.
5. What should innovators consider for patent strategies in Brazil?
Filing early, broad claim drafting, and considering international filings aligned with regional patent laws enhance protection.
References
[1] INPI. (2022). Patent examination procedures. INPI Official Guidelines.
[2] WIPO. (2023). Patent landscape reports: Pharmaceutical sector.
[3] Brazilian Patent Law. (2003). Law No. 9,279/1996, modified by Law No. 11,196/2005.
[4] USPTO. (2023). Patent Examination Guidelines.
[5] EPO. (2023). Guidelines for Examination.
